Skip to content
Screener

ABVC BioPharma, Inc. ABVC Q2 2026 earnings

Reported August 12, 2026 · Before market open

EPS-$0.03Beat by $0.37
Revenue estimate$113.3K
EPS estimate-$0.40

Next report

Nov 16, 2026 (in 3 months)
Revenue estimate$113.3K
EPS estimate-$0.40

FAQ

When did ABVC BioPharma, Inc. report Q2 2026 earnings?
ABVC BioPharma, Inc. (ABVC) reported Q2 2026 earnings on August 12, 2026 before market open.
What were ABVC BioPharma, Inc.'s Q2 2026 revenue and EPS?
ABVC BioPharma, Inc. reported eps of $-0.03 for Q2 2026.
Did ABVC BioPharma, Inc. beat estimates in Q2 2026?
EPS beat the consensus estimate of $-0.40 by $0.37.
How did ABVC BioPharma, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 76.9% from $-0.13.
Where can I find ABVC BioPharma, Inc.'s Q2 2026 SEC filings?
You can read the 8-K/A earnings release (0001213900-26-088165) and the 10-Q periodic report (0001213900-26-088348) directly on SEC EDGAR. The filing index links above go to sec.gov.